VasDeBlock medical ApS: Financial statements 2017
CVR: 37525758
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
VasDeBlock medical ApS (CVR 37525758) has filed annual accounts for 2017. In 2017, the company reported revenue of DKK 50,000 and a net result of DKK -133,210. The profit margin was -266.4%. Equity in the 2017 report amounted to DKK -25,296.
- Revenue
- DKK 50,000
- Gross Profit
- DKK -102,830
- Profit/Loss
- DKK -133,210
- Equity
- DKK -25,296
- Total Assets
- DKK 77,360
Official annual report
Keep an eye on VasDeBlock medical ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
VasDeBlock medical ApS has published its interim report for the period March 10, 2016 – December 31, 2016.
As of January 30, 2017, Einar Gjaldbæk Petersen has joined the board of directors of VasDeBlock medical ApS.
As of January 30, 2017, Peter Johansen Viereck has left the board of directors of VasDeBlock medical ApS.
About VasDeBlock medical ApS
VasDeBlock medical ApS is a Danish company of the type Anpartsselskab based in Karise, founded in 2016. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Mette Mikkelsen. The board consists of Nickolei Henrik Nagel (chair), Anders Brummerstedt-Madsen, Henrik Harboe and Niels Bøggild Lindeburg. The company's owners include Mette Mikkelsen, Nickolei Henrik Nagel and HOLDINGSELSKABET TEG AF 2011 ApS. In 2025, the company reported a gross profit of DKK -103,154 and a net result of DKK -103,099 compared with DKK -76,186 the year before. Equity in the 2025 report amounted to DKK 79,417.